Seagen Inc.
METHODS OF TREATING CANCER WITH NONFUCOSYLATED ANTI-CD70 ANTIBODIES

Last updated:

Abstract:

The invention provides methods of treating cancer, such as myeloid malignancies including myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), with nonfucosylated anti-CD70 antibodies.

Status:
Application
Type:

Utility

Filling date:

28 Dec 2020

Issue date:

22 Jul 2021